Abstract:Aim: Increasing evidence has proposed that mitochondrial abnormalities may be an important factor contributing to the development of heart failure with preserved ejection fraction (HFpEF). Hydrogen sulfide (H2S) has been suggested to play a pivotal role in regulating mitochondrial function. Therefore, the present study was designed to explore the protective effect of H2S on mitochondrial dysfunction in a multifactorial mouse model of HFpEF. Methods: Wild type, 8-week-old, male C57BL/6J mice or cardiomyocyte specific-Cse (Cystathionine γ-lyase, a major H2S-producing enzyme) knockout mice (CSEcko) were given high-fat diet (HFD) and l-NAME (an inhibitor of constitutive nitric oxide synthases) or standardized chow. After 4 weeks, mice were randomly administered with NaHS (a conventional H2S donor), ZLN005 (a potent transcriptional activator of PGC-1α) or vehicle. After additional 4 weeks, echocardiogram and mitochondrial function were evaluated. Expression of PGC-1α, NRF1 and TFAM in cardiomyocytes was assayed by Western blot. Results: Challenging with HFD and l-NAME in mice not only caused HFpEF but also inhibited the production of endogenous H2S in a time-dependent manner. Meanwhile the expression of PGC-1α and mitochondrial function in cardiomyocytes were impaired. Supplementation with NaHS not only upregulated the expression of PGC-1α, NRF1 and TFAM in cardiomyocytes but also restored mitochondrial function and ultrastructure, conferring an obvious improvement in cardiac diastolic function. In contrast, cardiac deletion of CSE gene aggravated the inhibition of PGC-1α-NRF1-TFAM pathway, mitochondrial abnormalities and diastolic dysfunction. The deleterious effect observed in CSEcko HFpEF mice was partially counteracted by pre-treatment with ZLN005 or supplementation with NaHS. Conclusion: Our findings have demonstrated that H2S ameliorates left ventricular diastolic dysfunction by restoring mitochondrial abnormalities via upregulating PGC-1α and its downstream targets NRF1 and TFAM, suggesting the therapeutic potential of H2S supplementation in multifactorial HFpEF.

Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice

Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis

Hydrogen Sulfide Attenuates Myocardial Ischemia-Reperfusion Injury by Preservation of Mitochondrial Function

Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α

H2S Protects Against Pressure Overload–Induced Heart Failure Via Upregulation of Endothelial Nitric Oxide Synthase

The Role of Endogenous and Exogenous Hydrogen Sulfide Following Pressure Overload Induced Hypertrophy and Heart Failure

Hydrogen Sulfide Attenuates Cardiac Dysfunction in a Rat Model of Heart Failure: a Mechanism Through Cardiac Mitochondrial Protection

Hydrogen Sulfide Cytoprotective Signaling Is Endothelial Nitric Oxide Synthase-Nitric Oxide Dependent

Protective effect of hydrogen sulphide against myocardial hypertrophy in mice.

Hydrogen Sulfide Modulates Endothelial–Mesenchymal Transition in Heart Failure

Endogenous Hydrogen Sulfide Regulation of Myocardial Injury Induced by Isoproterenol.

Hydrogen Sulfide Restores Cardioprotective Effects of Remote Ischemic Preconditioning in Aged Rats Via HIF-1α/Nrf2 Signaling Pathway

Hydrogen Sulfide Attenuates the Recruitment of CD11b + Gr-1 + Myeloid Cells and Regulates Bax/Bcl-2 Signaling in Myocardial Ischemia Injury

Hydrogen Sulfide Inhibits Myocardial Injury Induced by Homocysteine in Rats

Reduced Hydrogen Sulfide Bioavailability Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction

Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats.

Hydropersulfides (RSSH) Outperform Post-Conditioning and Other Reactive Sulfur Species in Limiting Ischemia-Reperfusion Injury in the Isolated Mouse Heart

Exogenous Hydrogen Sulfide Offers Neuroprotection on Intracerebral Hemorrhage Injury Through Modulating Endogenous H2S Metabolism in Mice

Hydrogen Sulfide and Its Possible Roles in Myocardial Ischemia in Experimental Rats

Hydrogen Sulfide Alleviates Acute Myocardial Ischemia Injury by Modulating Autophagy and Inflammation Response under Oxidative Stress

Hydrogen Sulfide Alleviates Cardiac Contractile Dysfunction in an Akt2-knockout Murine Model of Insulin Resistance: Role of Mitochondrial Injury and Apoptosis.